Periodontal Disease Therapeutics Market Intelligence Report Offers Growth Prospects

Periodontal (gums) diseases include infections of gums and its surrounding tissue which causes loosening of teeth. There are two forms of periodontal diseases which include gingivitis and periodontitis. Gingivitis is inflammation of gums and usually precedes periodontitis. Timely treatment of gingivitis leads to healthy gums, but if the inflammation is left unnoticed, it may lead to periodontitis causing an irreversible damage.

Obtain Report Details @ http://www.transparencymarketresearch.com/periodontal-disease-therapeutics-market.html

Oral health is a growing concern across the globe, where around 45% of the Americans suffered from periodontitis in 2012 according to American Academy of Periodontology. The study also indicated that the prevalence is higher in men (56%) as compared to women. According to Oral Health European Platform, an association for dental care, around 50% of the European population suffers from some periodontal disease. Similar statistics were discussed by a review article published title Global Prevalence on Periodontitis in 2012. According to the article, prevalence of severe periodontitis was in the range of 20-30% in India, while in Bangladesh, Canada and Germany it was more than 20%. The data statistics indicate that a large market opportunity exists because of the high prevalence of periodontal diseases worldwide.

The market for periodontal disease therapeutics can be segmented by therapeutic drugs as below:

Drug Therapy
PerioChip
Arestin
Atridox
Periostat

The market for periodontal disease therapeutics is leveraged by the rising prevalence of diabetes which is one of the major predisposing factors for infections in the body including gums. Smoking, hormonal changes are other reasons which lead to gum problems. With rising awareness about oral health and hygiene, the market is expected to grow in Asia-Pacific and other countries in Latin America and the Middle East. Cost of branded drugs is also a barrier for the growth of the market in developing economies. Although currently generic form of Periostat alone is available in the market, patent expiry is expected to fuel the market growth in the near future.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2026

Owing to high spending capacities, increased awareness, better reimbursement scenario, Europe and North America lad the market. Major players in the market include OraPharma, Inc., Kaken Pharmaceutical, and Fibrocell Sciences, Inc., DexcelPharma.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us

Transparency Market Research
90 State Street, Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.